Skip to Content

Notice

National Cancer Institute Amended; Notice of Meeting

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, July 17, 2019, 08:00 a.m. to 05:00 p.m., Start Printed Page 26692Hilton Washington/Rockville Hotel, 1750 Rockville Pike, Rockville, MD 08852 which was published in the Federal Register on May 13, 2019, 84 FR 20900.

This meeting notice is amended to change the name of the meeting from Advancing Cancer Immunotherapy by Mitigating-Immune related adverse events to Advancing Cancer Immunotherapy by Mitigating irAEs. The meeting is closed to the public.

Start Signature

Dated: June 3, 2019.

Melanie J. Pantoja,

Program Analyst, Office of Federal Advisory Committee Policy.

End Signature End Preamble

[FR Doc. 2019-11954 Filed 6-6-19; 8:45 am]

BILLING CODE 4140-01-P